Health Catalyst Inc (HCAT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Health Catalyst Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
HCAT's average price target has moved up $3.37 over the prior 150 days.
HCAT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HCAT as an investment opportunity.
- Health Catalyst Inc's number of analysts covering the stock is higher than 81% of all US stocks.
- Health Catalyst Inc's average analyst price target is higher than 83.2% of stocks in the small market cap category.
- The variance in analysts' estimates of HCAT is less than 23.3% of stocks in the small market cap category.
- The upside potential (average analyst target price relative to current price) of HCAT is higher than 24.82% of stocks in the small market cap category.
- The NA of HCAT is higher than practically none of all US stocks.
Is HCAT a Buy, Hold or Sell? See the POWR Ratings now!